Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.
Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores
Dr. Srimath BS, Dr. Sagar Thippanna Porammanavar, Dr. Ameeth Kulkarni
Chondrosarcomas are the second most common bone sarcomas, accounting for less than 0.5% of all cancers. The treatment plan can be improved by analyzing clinical characteristics and treatment patterns. The rarity and slowgrowing nature of this tumour often lead to prolonged symptoms and also initial misdiagnosis with avascular necrosis of the femur, benign bone lesions like chondroblastoma [1]. The initial reports of this patient suggested avascular necrosis of the femur head. His pain became severe and further investigations were done, MRI confirmed the diagnosis of Chondrosarcoma. An image-guided core needle biopsy suggested Clear Cell Chondrosarcoma (CCC). Wide local resection with negative margins forms the mainstay of treatment since intralesional procedures predispose to a high local recurrence rate. A prolonged follow-up is required since late local recurrences of tumour and distant metastases are common.